David B. Roberts - 05 Feb 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: President and Director, Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 05 Feb 2026
Net transactions value: +$99,979
Form type: 4
Filing time: 06 Feb 2026, 16:48:58 UTC
Previous filing: 15 Dec 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Roberts David B	President and Director, Director	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON	/s/ Laurie A. Churchill, Attorney-in-fact	06 Feb 2026	0001365731

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$99,639	+2,672	+12%	$37.29	24,923	05 Feb 2026	Direct	F1
transaction	LMAT	Common Stock	Options Exercise	$340	+7	+0.03%	$48.60	24,930	05 Feb 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Stock Option (Right to Buy)	Options Exercise	$0	-2,672	-100%	$0.000000	0	05 Feb 2026	Common Stock	2,672	$37.29	Direct	F2
transaction	LMAT	Stock Option (Right to Buy)	Options Exercise	$0	-7	-0.05%	$0.000000	14,054	05 Feb 2026	Common Stock	7	$48.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2	This option is fully vested and exercisable.